Viracta Therapeutics Inc (VIRX)
0.822
-0.02
(-2.14%)
USD |
NASDAQ |
May 03, 16:00
0.822
0.00 (0.00%)
After-Hours: 17:43
Viracta Therapeutics Free Cash Flow (Quarterly): -10.03M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.03M |
| September 30, 2023 | -10.48M |
| June 30, 2023 | -8.179M |
| March 31, 2023 | -11.34M |
| December 31, 2022 | -7.903M |
| September 30, 2022 | -7.158M |
| June 30, 2022 | -9.078M |
| March 31, 2022 | -11.36M |
| Date | Value |
|---|---|
| December 31, 2021 | -7.23M |
| September 30, 2021 | -11.83M |
| June 30, 2021 | -6.598M |
| March 31, 2021 | 2.551M |
| December 31, 2020 | -4.541M |
| September 30, 2020 | -4.26M |
| June 30, 2020 | -3.65M |
| March 31, 2020 | -3.658M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.83M
Minimum
Sep 2021
2.551M
Maximum
Mar 2021
-7.172M
Average
-7.566M
Median
Free Cash Flow (Quarterly) Benchmarks
| XOMA Corp | -3.927M |
| Marinus Pharmaceuticals Inc | -27.03M |
| Cartesian Therapeutics Inc | -23.35M |
| Adial Pharmaceuticals Inc | -1.223M |
| NovaBay Pharmaceuticals Inc | -0.316M |